Evidence map›Paper›PMID 26380554›Full record

ReviewCancer growth and metastasis2015

Skin Carcinogenesis Studies Using Mouse Models with Altered Polyamines.

Shannon L Nowotarski, David J Feith, Lisa M Shantz

Open access · bronzeAbstract readReview
In one paragraph

Review in Cancer growth and metastasis, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The Association between Spermidine/Spermine NInternational journal of molecular sciences · 2022
    Review
  5. Review
  6. Spermidine/spermine-NAlzheimer's research & therapy · 2019
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. ANIMAL MODELS OF CANCER BIOLOGY.Cancer growth and metastasis · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Shannon L NowotarskiDepartment of Biochemistry, The Pennsylvania State University Berks College, Reading, PA, USA.
David J FeithUniversity of Virginia Cancer Center and Department of Medicine, Hematology and Oncology, University of Virginia, Charlottesville, VA, USA.
Lisa M ShantzDepartment of Cellular and Molecular Physiology, The Pennsylvania State University College of Medicine, Hershey, PA, USA.
Pennsylvania State University · US

Funding

MAMMALIAN POLYAMINE METABOLISMR01CA018138 · NCI · UNIVERSITY OF VIRGINIA · PI FEITH, DAVID J. · 1985 to 2015
$2.8M
MAMMALIAN POLYAMINE METABOLISMR37CA018138 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI PEGG, ANTHONY E · 1988 to 2004
$1.7M
Role of ornithine decarboxylase in Ras transformationR01CA082768 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI SHANTZ, LISA M · 1999 to 2006
$1.4M
Epidermal stem cell properties in mice with altered polyaminesR03CA142051 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI SHANTZ, LISA M · 2009 to 2010
$155k
NCI NIH HHS R01 CA018138NCI NIH HHS R01 CA082768NCI NIH HHS R03 CA142051NCI NIH HHS R37 CA018138
6 · The paper itself

Abstract

Nonmelanoma skin cancer (NMSC) is a major health concern worldwide. With increasing numbers in high-risk groups such as organ transplant recipients and patients taking photosensitizing medications, the incidence of NMSC continues to rise. Mouse models of NMSC allow us to better understand the molecular signaling cascades involved in skin tumor development in order to identify novel therapeutic strategies. Here we review the models designed to determine the role of the polyamines in NMSC development and maintenance. Elevated polyamines are absolutely required for tumor growth, and dysregulation of their biosynthetic and catabolic enzymes has been observed in NMSC. Studies using mice with genetic alterations in epidermal polyamines suggest that they play key roles in tumor promotion and epithelial cell survival pathways, and recent clinical trials indicate that pharmacological inhibitors of polyamine metabolism show promise in individuals at high risk for NMSC.

Indexed as

chemical carcinogenesismouse modelsnonmelanoma skin cancerpolyaminesUVB

Identifiers

PMID26380554
PMCPMC4558889
OpenAlexW1910116874

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.